Streptozotocin Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
112
|
|
0.300 |
None |
1.000 |
1 |
|
1998 |
1998 |
Alloxan Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
112
|
|
0.300 |
None |
1.000 |
1 |
|
1998 |
1998 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.300 |
None |
1.000 |
1 |
|
1998 |
1998 |
melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3087
|
515
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.200 |
None |
1.000 |
1 |
|
1997 |
1997 |
Nephrotic Syndrome
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
384
|
45
|
0.200 |
None |
1.000 |
1 |
|
2008 |
2008 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
8 |
7
|
2010 |
2019 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
7 |
7
|
2010 |
2019 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
545
|
1440
|
0.100 |
None |
1.000 |
6 |
7
|
2015 |
2019 |
Serum LDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
269
|
555
|
0.100 |
None |
1.000 |
2 |
1
|
2010 |
2013 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
2 |
6
|
2018 |
2019 |
Serum Alanine Aminotransferase Measurement
|
phenotype |
|
Laboratory Procedure
|
41
|
77
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Alanine aminotransferase measurement
|
phenotype |
|
Laboratory Procedure
|
41
|
77
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Alcohol consumption
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
210
|
535
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
White Blood Cell Count procedure
|
phenotype |
|
Laboratory Procedure
|
681
|
1322
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Steatohepatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1143
|
75
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2019 |
Fatty Liver
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
875
|
35
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Overnutrition
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
54
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |